Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, USA, July 30, 2025 (GLOBE NEWSWIRE) -- Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight The antibody discovery market is expanding,...
-
Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Antibody Discovery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Antibody Discovery...
-
Ottawa, April 11, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global antibody discovery market size is set to rise from USD 8,700 million in 2024 to USD 22,570 million in 2034,...
-
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
-
Partnerships will employ Vaccinex’s ActivMAb® tech. Successful antibody discovery campaigns for cancer immunotherapy to be presented at SITC Nov 9, 2024.
-
ROCHESTER, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
-
Wilmington, Delaware, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Custom Antibody Services Market by Service (Antibody Development, Antibody Production and...
-
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Antibody Discovery Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global antibody discovery market has grown...
-
Expect Topline Data for Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024. $17.9 million of new financing in Q4 2023 and Q1 2024.